Corbus Pharmaceuticals Holdings Inc (CRBP)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -130.02 | -76.408 | -97.698 | -148.66 | -146.951 | -43.461 | -48.663 | -94.314 |
Return on Equity (%) | -223.403 | -97.213 | -130.52 | -424.286 | -432.676 | -79.802 | -82.954 | -341.982 |
Return on Invested Capital (%) | -224.261 | -97.762 | -133.175 | -459.582 | -358.705 | -76.371 | -60.101 | -221.253 |
Operating Margin (%) | -1046.52 | -1328.77 | -1154.542 | -197.693 | -2800.127 | -4967.007 | N/A | N/A |
Net Profit Margin (%) | -1046.52 | -1328.77 | -1154.542 | -197.693 | -2826.238 | -5174.603 | N/A | N/A |
Book Value Per Share | 0.2 | 1.039 | 0.481 | 0.095 | 0.458 | 0.552 | 7.909 | -1.561 |
Earnings Per Share | -0.448 | -0.583 | -0.972 | -1.105 | -1.126 | -0.364 | -10.153 | -10.082 |
Cash Per Share | 0.336 | 1.125 | 0.729 | 0.491 | 0.864 | 0.2 | 4.076 | 3.102 |
Working Capital Per Share | 0.19 | 1.031 | 0.457 | 0.051 | 0.609 | 0.664 | 11.398 | -1.887 |
Operating Profit Per Share | 0.043 | 0.044 | 0.084 | 0.559 | 0.04 | 0.007 | N/A | N/A |
EBIT Per Share | -0.448 | -0.583 | -0.972 | -1.105 | -1.126 | -0.364 | -10.153 | -10.082 |
EBITDA Per Share | -0.448 | -0.583 | -0.972 | -1.105 | -1.126 | -0.364 | -10.153 | -10.082 |
Free Cash Flow Per Share | -0.442 | -0.575 | -0.941 | -1.074 | -1.132 | -0.372 | -10.333 | -10.227 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 44,68M | 55,6M | 57,25M | 64,67M | 98,85M | 125,23M | 4,17M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 4,17M | N/A | 4,42M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 143,6M |
Ratio cours/bénéfice | -3,08 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 10,01 |
Ratio prix/valeur comptable | -19,9 |
Rendement de dividende | - |
Actions en circulation | 12,18M |
Volume moyen (1 semaine) | 159,46k |
Volume moyen (1 mois) | 283,25k |
Variation sur 52 semaines | 91,53% |
Plus haut sur 52 semaines | 61,90 |
Plus bas sur 52 semaines | 5,6654 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales